Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CureVac
CureVac
CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine
Yahoo Finance
Thu, 11/18/21 - 10:36 am
CureVac
MRNA
vaccines
COVID-19
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report
Endpoints
Fri, 10/15/21 - 10:57 am
CureVac
Bayer
vaccines
COVID-19
MRNA
drug manufacturing
CureVac drops COVID-19 vaccine candidate; shifts focus to second-generation mRNA program
Biopharma Reporter
Tue, 10/12/21 - 11:06 am
CureVac
vaccines
COVID-19
MRNA
GSK
CureVac Adjusts to Vaccine Demand by Reducing European mRNA Manufacturing Network
BioSpace
Tue, 09/14/21 - 10:39 pm
CureVac
MRNA
Europe
vaccines
drug manufacturing
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Motley Fool
Fri, 08/27/21 - 10:54 am
CureVac
Boehringer Ingelheim
MRNA
lung cancer
vaccines
Moderna Therapeutics
BioNTech
GSK, CureVac's next-gen COVID-19 vaccine shows promise in monkey trial
Reuters
Mon, 08/16/21 - 10:22 pm
GSK
CureVac
MRNA
COVID-19
vaccines
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, heaping more woe to the biotech
Fierce Biotech
Mon, 08/16/21 - 12:09 pm
CureVac
MRNA
Boehringer Ingelheim
COVID-19
vaccines
CureVac to ‘plow forward’ with Covid vaccine despite disappointing results
CNBC
Thu, 07/1/21 - 11:00 am
CureVac
COVID-19
vaccines
clinical trials
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
Motley Fool
Wed, 06/23/21 - 10:40 am
Pfizer
Moderna Therapeutics
AstraZeneca
CureVac
vaccines
COVID-19
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer
Motley Fool
Fri, 06/18/21 - 10:57 am
MRNA
vaccines
COVID-19
CureVac
Moderna Therapeutics
Pfizer
clinical trials
GSK, Bayer stand by CureVac following 'disappointing' COVID-19 vaccine trial flop
Fierce Pharma
Thu, 06/17/21 - 10:44 pm
CureVac
Bayer
GSK
vaccines
COVID19
CureVac's first-gen COVID-19 vaccine misses the mark with 47% efficacy, as share price halves in after-hours trading
Fierce Biotech
Wed, 06/16/21 - 11:21 pm
CureVac
MRNA
vaccines
COVID-19
CureVac's Potential Has Wall Street Sending Mixed Signals
Motley Fool
Mon, 04/26/21 - 11:17 pm
CureVac
vaccines
COVID-19
Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra
Fierce Pharma
Thu, 04/15/21 - 11:21 am
Novartis
COVID-19
Pfizer
BioNTech
CureVac
Roche
API
Actemra
CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study
Biopharma Reporter
Tue, 03/23/21 - 11:18 pm
CureVac
COVID-19
vaccines
B.1.351 variant
COVID-19 variants
Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU
Endpoints
Thu, 03/4/21 - 09:48 am
Novartis
vaccines
CureVac
COVID-19
drug manufacturing
CureVac's COVID vaccine enters EMA's rolling review
RAPS.org
Sat, 02/13/21 - 11:04 pm
CureVac
EMA
Europe
vaccines
COVID-19
CVnCoV
Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production
Xtalks
Fri, 02/5/21 - 10:48 am
vaccines
COVID-19
drug manufacturing
Bayer
GSK
Sanofi
CureVac
GSK/CureVac target new COVID variants with next-gen shot
Pharmaforum
Wed, 02/3/21 - 10:43 am
GSK
CureVac
vaccines
COVID-19
Pages
« first
‹ previous
1
2
3
4
next ›
last »